These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18088504)

  • 1. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
    Yang KH; Lee JH; Lee MG
    J Pharm Pharmacol; 2008 Jan; 60(1):45-53. PubMed ID: 18088504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
    Yang KH; Choi YH; Lee U; Lee JH; Lee MG
    J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats.
    Choi HD; Kang HE; Chung HJ; Bae SK; Shin KN; Lee MG
    Biopharm Drug Dispos; 2007 Nov; 28(8):445-54. PubMed ID: 17847127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.
    Lee DY; Shin HS; Bae SK; Lee MG
    Biopharm Drug Dispos; 2006 Jul; 27(5):209-18. PubMed ID: 16586464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
    Yu SY; Chung HC; Kim EJ; Kim SH; Lee I; Kim SG; Lee MG
    J Pharm Pharmacol; 2002 Dec; 54(12):1687-92. PubMed ID: 12542900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of 5-fluorouracil in mutant Nagase analbuminemic rats: faster metabolism of 5-fluorouracil via CYP1A.
    Choi YH; Bae SK; Kim SO; Lee MG
    Biopharm Drug Dispos; 2007 Mar; 28(2):87-95. PubMed ID: 17230597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on the pharmacokinetics of theophylline in rats: return of the parameters in 96-hour KPLPS rats to the control levels.
    Yang KH; Jung YS; Lee DY; Lee JH; Kim YC; Lee MG
    Drug Metab Dispos; 2008 May; 36(5):811-5. PubMed ID: 18308837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats.
    Chung HJ; Choi YH; Kim SH; Lee MG
    J Pharm Pharmacol; 2006 Apr; 58(4):449-57. PubMed ID: 16597362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation.
    Kim YC; Lee AK; Lee JH; Lee I; Lee DC; Kim SH; Kim SG; Lee MG
    Eur J Pharm Sci; 2005 Sep; 26(1):114-23. PubMed ID: 15985363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of enzyme inducers and inhibitors on the pharmacokinetics of oltipraz in rats.
    Bae SK; Lee SJ; Kim YH; Kim T; Lee MG
    J Pharm Pharmacol; 2005 Apr; 57(4):443-52. PubMed ID: 15831204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.
    Choi YH; Lee MG
    Br J Pharmacol; 2006 Oct; 149(4):424-30. PubMed ID: 16940989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats.
    Kim EJ; Suh OK; Lee MG
    Life Sci; 2003 Jan; 72(11):1231-45. PubMed ID: 12570924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of aciclovir on metabolism of theophylline and expression of hepatic cytochrome P450 1A2 in rats.
    Nadai M; Kato M; Yasui K; Kimura M; Zhao YL; Ueyama J; Tsunekawa Y; Yoshizumi H; Hasegawa T
    Biol Pharm Bull; 2007 Mar; 30(3):562-8. PubMed ID: 17329857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
    Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
    J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of decursinol angelate on the pharmacokinetics of theophylline and its metabolites in rats.
    Chae JW; An JH; Kang W; Ma Jy; Kwon KI
    Food Chem Toxicol; 2012 Oct; 50(10):3666-72. PubMed ID: 22771369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cytochromes P4501A induction and inhibition on the disposition of the cognition activator tacrine in rat hepatic preparations.
    Bezek S; Kukan M; Pool WF; Woolf TF
    Xenobiotica; 1996 Sep; 26(9):935-46. PubMed ID: 8893040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herb-drug interaction of Andrographis paniculata extract and andrographolide on the pharmacokinetics of theophylline in rats.
    Chien CF; Wu YT; Lee WC; Lin LC; Tsai TH
    Chem Biol Interact; 2010 Mar; 184(3):458-65. PubMed ID: 20096675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a new chemoprotective agent, 2-(allylthio)pyrazine, on the pharmacokinetics of intravenous theophylline in rats.
    Han KS; Lee MG
    Int J Pharm; 1999 Jul; 184(2):237-42. PubMed ID: 10387953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cytochrome P450 (CYP) inducers and inhibitors on ondansetron pharmacokinetics in rats: involvement of hepatic CYP2D subfamily and 3A1/2 in ondansetron metabolism.
    Yang SH; Lee MG
    J Pharm Pharmacol; 2008 Jul; 60(7):853-61. PubMed ID: 18549671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of coenzyme Q10 on the pharmacokinetic parameters of theophylline.
    Baskaran R; Shanmugam S; Nagayya-Sriraman S; Kim JH; Jeong TC; Yong CS; Choi HG; Yoo BK
    Arch Pharm Res; 2008 Jul; 31(7):938-44. PubMed ID: 18704339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.